599 related articles for article (PubMed ID: 18502017)
21. Gene expression profiling of responses to dimethylarsinic acid in female F344 rat urothelium.
Sen B; Wang A; Hester SD; Robertson JL; Wolf DC
Toxicology; 2005 Nov; 215(3):214-26. PubMed ID: 16122865
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic effects of S-(dimethylarsino)-glutathione: a putative intermediate metabolite of inorganic arsenicals.
Hirano S; Kobayashi Y
Toxicology; 2006 Oct; 227(1-2):45-52. PubMed ID: 16945460
[TBL] [Abstract][Full Text] [Related]
23. Characterization of intracellular inclusions in the urothelium of mice exposed to inorganic arsenic.
Dodmane PR; Arnold LL; Muirhead DE; Suzuki S; Yokohira M; Pennington KL; Dave BJ; Lu X; Le XC; Cohen SM
Toxicol Sci; 2014 Jan; 137(1):36-46. PubMed ID: 24097667
[TBL] [Abstract][Full Text] [Related]
24. Time course of urothelial changes in rats and mice orally administered arsenite.
Arnold LL; Suzuki S; Yokohira M; Kakiuchi-Kiyota S; Pennington KL; Cohen SM
Toxicol Pathol; 2014 Jul; 42(5):855-62. PubMed ID: 23690446
[TBL] [Abstract][Full Text] [Related]
25. Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells.
Naranmandura H; Carew MW; Xu S; Lee J; Leslie EM; Weinfeld M; Le XC
Chem Res Toxicol; 2011 Sep; 24(9):1586-96. PubMed ID: 21815631
[TBL] [Abstract][Full Text] [Related]
26. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water.
Kenyon EM; Hughes MF; Adair BM; Highfill JH; Crecelius EA; Clewell HJ; Yager JW
Toxicol Appl Pharmacol; 2008 Nov; 232(3):448-55. PubMed ID: 18706920
[TBL] [Abstract][Full Text] [Related]
27. Inorganic and methylated arsenic compounds induce cell death in murine macrophages via different mechanisms.
Sakurai T; Kaise T; Matsubara C
Chem Res Toxicol; 1998 Apr; 11(4):273-83. PubMed ID: 9548797
[TBL] [Abstract][Full Text] [Related]
28. Dimethylarsinic acid: results of chronic toxicity/oncogenicity studies in F344 rats and in B6C3F1 mice.
Arnold LL; Eldan M; Nyska A; van Gemert M; Cohen SM
Toxicology; 2006 Jun; 223(1-2):82-100. PubMed ID: 16677751
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxicity and gene expression changes induced by inorganic and organic trivalent arsenicals in human cells.
Dodmane PR; Arnold LL; Kakiuchi-Kiyota S; Qiu F; Liu X; Rennard SI; Cohen SM
Toxicology; 2013 Oct; 312():18-29. PubMed ID: 23876855
[TBL] [Abstract][Full Text] [Related]
30. Toxicity of a trivalent organic arsenic compound, dimethylarsinous glutathione in a rat liver cell line (TRL 1215).
Sakurai T; Kojima C; Kobayashi Y; Hirano S; Sakurai MH; Waalkes MP; Himeno S
Br J Pharmacol; 2006 Dec; 149(7):888-97. PubMed ID: 17043674
[TBL] [Abstract][Full Text] [Related]
31. Role of the alkali labile sites, reactive oxygen species and antioxidants in DNA damage induced by methylated trivalent metabolites of inorganic arsenic.
Soto-Reyes E; Del Razo LM; Valverde M; Rojas E
Biometals; 2005 Oct; 18(5):493-506. PubMed ID: 16333750
[TBL] [Abstract][Full Text] [Related]
32. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species.
Aposhian HV; Zakharyan RA; Avram MD; Sampayo-Reyes A; Wollenberg ML
Toxicol Appl Pharmacol; 2004 Aug; 198(3):327-35. PubMed ID: 15276412
[TBL] [Abstract][Full Text] [Related]
33. Urothelial cytotoxicity and regeneration induced by dimethylarsinic acid in rats.
Cohen SM; Yamamoto S; Cano M; Arnold LL
Toxicol Sci; 2001 Jan; 59(1):68-74. PubMed ID: 11134545
[TBL] [Abstract][Full Text] [Related]
34. Effects of inorganic arsenic on the rat and mouse urinary bladder.
Suzuki S; Arnold LL; Ohnishi T; Cohen SM
Toxicol Sci; 2008 Dec; 106(2):350-63. PubMed ID: 18728046
[TBL] [Abstract][Full Text] [Related]
35. Blockade and enhancement of glutamate receptor responses in Xenopus oocytes by methylated arsenicals.
Krüger K; Gruner J; Madeja M; Hartmann LM; Hirner AV; Binding N; Musshoff U
Arch Toxicol; 2006 Aug; 80(8):492-501. PubMed ID: 16474957
[TBL] [Abstract][Full Text] [Related]
36. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment.
Cohen SM; Arnold LL; Eldan M; Lewis AS; Beck BD
Crit Rev Toxicol; 2006 Feb; 36(2):99-133. PubMed ID: 16736939
[TBL] [Abstract][Full Text] [Related]
37. Speciation of arsenic in biological samples.
Mandal BK; Ogra Y; Anzai K; Suzuki KT
Toxicol Appl Pharmacol; 2004 Aug; 198(3):307-18. PubMed ID: 15276410
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes.
Vega L; Styblo M; Patterson R; Cullen W; Wang C; Germolec D
Toxicol Appl Pharmacol; 2001 May; 172(3):225-32. PubMed ID: 11312651
[TBL] [Abstract][Full Text] [Related]
39. Mitochondria are the main target organelle for trivalent monomethylarsonous acid (MMA(III))-induced cytotoxicity.
Naranmandura H; Xu S; Sawata T; Hao WH; Liu H; Bu N; Ogra Y; Lou YJ; Suzuki N
Chem Res Toxicol; 2011 Jul; 24(7):1094-103. PubMed ID: 21648415
[TBL] [Abstract][Full Text] [Related]
40. Evidence for toxicity differences between inorganic arsenite and thioarsenicals in human bladder cancer cells.
Naranmandura H; Ogra Y; Iwata K; Lee J; Suzuki KT; Weinfeld M; Le XC
Toxicol Appl Pharmacol; 2009 Jul; 238(2):133-40. PubMed ID: 19442679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
